Modi, Shah likely to address rallies in Udupi, Mangaluru, Uttara Kannada ahead of 2018 polls

Bengaluru, Feb 14: Karnataka Legislative Assembly Speaker Vishvesha Hegde Kageri on Friday announced continuation of ban on private TV channels from live coverage of the Budget Session being held this Month and next month.

Addressing a press conference here, Mr Kageri said that the ban was imposed on the lines of practice in Lok Sabha and Rajya Sabha in the Parliament. Private channels will not be allowed to cover live on going session instead they will be provided with clippings by the concerned Department as was done during the previous Session.

For the first time in the history the BJP government, which had come to power for the second time in the state last year after pulling down Congress-JDS coalition government, had banned live coverage of the session by private channels and despite Chief Minister BS Yediyurappa's appeal the ban was not lifted.

Newsroom, Jun 16: A 35-year-old Kannada lecturer died in a motorbike accident at Tumkuru in Karnataka.

The deceased is K N Swamy, who was a guest lecturer in Department of Kannada at Central University of Kerala located at Periya in Kasaragod district.

The accident occurred on Sunday afternoon when he was riding his motorbike.

Swamy was also a writer and poet in Kannada.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.